Browsing Category
Solid Dispersion
Tailoring the release of highly loaded amorphous solid dispersions via additive manufacturing
Abstract
In the last decades, tremendous improvements have been made in enhancing the bioavailability of poorly soluble active pharmaceutical ingredients (APIs). Lately, their customisation potential has become a reality through filament-based 3D-printing (3DP). Highly loaded oral amorphous solid…
Read More...
Read More...
A powerful carrier adapted for HME process to formulate stable ASD’s while avoiding downstream…
This poster was presented at the ECP 2025 in Porto
Introduction
Hot melt extrusion (HME) is generally applied for the formulation of amorphous solid dispersions (ASD) aiming to enhance the solubility of poorly water-soluble drugs . The aim of this work was to evaluate the use of an innovative dry…
Read More...
Read More...
A Mini-Review on Enhancing Solubility in Topical Hydrogel Formulations Using Solid Dispersion…
Abstract
The solubility behavior of drugs is a critical factor in formulation development. Approximately 40–45% of new drugs face market entry challenges due to low water solubility. Enhancing drug bioavailability is thus essential in developing pharmaceutical dosage forms. Many biopharmaceutical…
Read More...
Read More...
Compaction Characterisation of Piroxicam Amorphous Solid Dispersions Formulations
See another MEDELPHARM bulletin:
Amorphous solid dispersions (ASDs) have been widely used to improve the bioavailability of poorly water-soluble drugs . They are comprised of high molar mass polymer carriers that stabilise the active pharmaceutical ingredients (APIs) in their amorphous state.…
Read More...
Read More...
Formulation Development and Compaction of Itraconazole Amorphous Solid Dispersions Tablet Using…
Itraconazole (ITZ), a BCS Class II drug exhibiting low solubility (1-4 ng/ mL in water) requires formulation enhancement to achieve enhanced bioavailability. To tackle this problem amorphous solid dispersions (ASDS) of ITZ in a polymer matrix (Kollidon® VA64) were produced using the Hot Melt…
Read More...
Read More...
Increased Dissolution Rate And Decreased Processing Temperature For Immediate Release FDM 3d Printed…
In recent years, there has been much interest in three-dimensional (3D) printing for the development of personalized and on-demand medications for better therapy. In 3D-printing, materials are deposited layer by layer to form tablets and pellets. Among various 3D-printing technologies, the fused…
Read More...
Read More...
Development and characterisation of polymeric solid dispersed systems of hesperidin, obtained by…
Abstract
The flavonoid hesperidin is a crucial, biologically active substance of great interest because of its polypharmacological properties and high safety profile. However, its widespread use of this bioflavonoid in remedies for the treatment and prevention of various diseases is limited by its…
Read More...
Read More...
Development of tablet formulations containing genistein solid dispersion optimized using Box-Behnken…
Abstract
Genistein, a bioactive isoflavone, offers therapeutic potential but is hindered by poor water solubility, limiting its oral bioavailability. This study aimed to enhance genistein’s solubility by developing solid dispersion (SD) and formulating them into tablets. The SDs were prepared using…
Read More...
Read More...
Developing Soluplus®-Based Microparticle Amorphous Solid Dispersions with High Drug Loading for…
Abstract
Amorphous solid dispersion (ASD) is one of the most studied strategies for improving the dissolution performance of poorly water-soluble drugs, but ASDs often have low drug loadings, thereby necessitating larger dosage sizes. This study intended to create Soluplus® (SOL)-based…
Read More...
Read More...
Assessing the Impacts of Drug Loading and Polymer Type on Dissolution Behavior and Diffusive Flux of…
Abstract
It is desirable but remains challenging to develop high drug load amorphous solid dispersions (ASDs) without compromising their quality attributes and bio-performance. In this work, we investigated the impacts of formulation variables, such as drug loading (DL) and polymer type, on…
Read More...
Read More...